摘要
以邻苯二甲酸酐为起始原料,经保护、取代、缩合、去保护、成盐等步骤,合成了苯磺酸氨氯地平,对其中关键步骤工艺进行了改进,总收率提高10%,降低了生产成本。
出处
《宁波化工》
2010年第2期24-25,共2页
Ningbo Chemical Industry
参考文献6
-
1石卫兵,赖宜生,张奕华.苯磺酸氨氯地平的合成研究[J].中国药物化学杂志,2006,16(3):161-164. 被引量:7
-
2刘鹤超,冯亚青.新一代心血管药物氨氯地平的合成[J].化学工业与工程,2006,23(1):88-92. 被引量:8
-
3李进禧.新一代的钙通道阻滞剂氨氯地平[J].新药与临床,1992,11(5):307-309. 被引量:18
-
4YOUNG2HO,KIM NAM2DU,LEE KYUNG2IK,et al.Method for preparing amlodipine. US:2002132834A1 . 2002
-
5LAURA COPPL,YOLANDA GASANZ GULLEN,JULLOCAMPON PARDO.Intermediate for the synthesis ofamlodipine,a process for the corresponding use. US:6603006B2 . 2003
-
6Arun K P,Brahmader C D,Balasaheb D S,et al.Process forthe prepatation of anti-ischemic and anti-hypertensive drugamlodipine besylate. us:20040044208A1 . 2004
二级参考文献18
-
1CAMPBELL SIMON FRASER, CROSS PETER EDWARD,STUBBS JOHN KENDRICK. Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production,and pharmaceutical compositions containing them [ P ]. EP:0060674A1,1982-09-22.
-
2BAEK U HYEON, KIM HYEONG GEUN, KIM JI HAN, et al. Method for preparation amlodipine besylate [P]. KR:00217240,1999-06-03.
-
3ARUN KUMAR PUROHIT, BRAHMADER CHILU DESAL,BALSAHEB DASHRATH SHETE. Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate [P]. US: 2004044218A1,2004-03-04.
-
4CAMPBELL SIMON FRASER, CROSS PETER EDWARD,STUBBS JOHN KENDRICK. Dihydropyridine anti-ischemicand antihypertensive agents, processes for their production,and pharmaceutical compositions containing them [ P ]. EP:0089167,1983-09-21.
-
5SIMON F CAMPBELL, PETER E CROSS, JOHN KSTUBBS. 2-(Secondary aminoalkoxymethyl) dihydropyfidine derivatives as anti-sichemic and antihypertensive agents[P]. US:45772909,1986-02-25.
-
6JERIHA ALENKA, COPAR ANTON DR, FURLANBORUT. A process for the preparation of amlodipine benzenesulphonate [P]. EP: 0599220A1,1994-06-01.
-
7VERECZKEY GYOERGYI DONATH, BLASKO G ABOR,SIMIG GYULA, et al. Process for the preparation of a dihydropyridine derivative[P]. US: 6046337A1, 2000-04-04.
-
8YOUNG-HO, KIM NAM-DU, LEE KYUNG-IK, et al.Method for preparing amlodipine [ P ]. US:2002132834A1,2002-09-19.
-
9LAURA COPPL, YOLANDA GASANZ GULLEN, JULLOCAMPON PARDO. Intermediate for the synthesis of amlodipine,a process for the corresponding use[P]. US:6603006B2,2003-08-05.
-
10Davison E, Well S, James I. Pharmaceutically acceptable salts[P]. US.-4879303, 1989 - 11 - 07.
共引文献29
-
1崔惠珍,田兆柱.新一代钙通道阻滞剂─—氨氯地平[J].中国药业,1997,6(8):20-21.
-
2刘鹤超,冯亚青.新一代心血管药物氨氯地平的合成[J].化学工业与工程,2006,23(1):88-92. 被引量:8
-
3袁成,焦素云,王景祥.氨氯地平片在健康人和高血压患者中的药物动力学[J].中国医院药学杂志,1996,16(10):435-437. 被引量:8
-
4刁树玲,曹广智,刘国萍.氨氯地平的药理与临床应用[J].中国医院药学杂志,1997,17(3):129-131. 被引量:5
-
5刘树文,呼红英.钙拮抗剂治疗高血压[J].中国医院药学杂志,1997,17(6):265-266. 被引量:2
-
6尚姝,杜迎翔,张锋,范青峰,孙雯,李萍.手性药物苯磺酸氨氯地平与人血清白蛋白相互作用的荧光光谱法研究[J].中国药学杂志,2008,43(4):311-314. 被引量:3
-
7陈利群.马来酸氨氯地平精制工艺的绿色设计分析[J].化学工业与工程,2008,25(4):328-334.
-
8祝世法,厉朝喜.氨氯地平与维拉帕米缓释片降压疗效的比较[J].浙江医学,1997,19(3):176-177. 被引量:1
-
9陆定国.新药络活喜与倍他洛克联合治疗难治性高血压38例[J].右江民族医学院学报,1998,20(S1):57-58.
-
10韩希标,曹殿国.钙通道阻滞剂治疗高血压病的疗效概况[J].药学实践杂志,1998,16(3):139-140.
同被引文献8
-
1计秀玲.长托普利片治疗中年人舒张期高血压33例临床分析[J].中国现代药物应用,2009,3(5):118-119. 被引量:2
-
2董火林.106例青年高血压病的临床分析[J].中原医刊,2005,32(22):15-16. 被引量:15
-
3林晨.单纯舒张期高血压22例观察[J].航空航天医药,2005,16(4):23-23. 被引量:2
-
4耿文学.比索洛尔对老年高血压患者舒张功能的影响[J].河北医药,2010,32(1):35-36. 被引量:2
-
5何红娟,许先继,陈康.福辛普利联合合贝爽对老年单纯收缩期高血压患者疗效观察[J].中国现代医生,2010,48(6):9-10. 被引量:1
-
6吴敬,陈伟,张涛,杨容.苯磺酸氨氯地平联合贝那普利治疗高血压110例疗效观察[J].西部医学,2010,22(8):1463-1464. 被引量:27
-
7张天成,赵改书,刘炬.小剂量比索洛尔、氯沙坦治疗对左室舒张功能的影响[J].高血压杂志,2002,10(2):125-126. 被引量:13
-
8张海生,张东旭,那开宪.福辛普利治疗原发性高血压46例临床疗效观察[J].中国医药导刊,2002,4(4):305-306. 被引量:4